HSPB1 and atrial fibrillation: Based on these findings, future research should focus on establishing HSP expression profiling criteria for AF patients, developing highly sensitive HSPB1 detection technologies, and conducting targeted clinical trials for HSP-deficient subgroups to advance precision therapy for AF (van Marion et al., 2019).